Diagnosis and management of hepatic encephalopathy: A summary for patients
Ellen W. Green, Arnab Mitra – 21 July 2022
Reply
Laurens A. Kleef, Milan J. Sonneveld, Robert J. Knegt – 20 July 2022
Acute hepatitis of unknown origin in children: Behind the statistics
Randa Elsheikh, Hoang Thuy Tien, Abdelrahman M. Makram, Nguyen Thanh Van, Trang Thi Bich Le, Tamilarasy Vasanthakumaran, Nguyen Tien Huy – 20 July 2022 – Since April 2022, the world has been witnessing a rapidly spreading outbreak of acute hepatitis of unknown origin in children < 16 years old that has affected several countries around the world. Most of the cases have presented with the clinical picture of severe hepatitis that has led to resorting to liver transplantation in several cases.
Reply
Kwang Yoon Kim, Kyung‐Won Hong, Bom Taeck Kim – 20 July 2022
Reply
Dong Hyun Sinn, Danbee Kang, Eliseo Guallar, Juhee Cho, Geum‐Youn Gwak – 20 July 2022
Hepatocyte β‐catenin loss is compensated by Insulin‐mTORC1 activation to promote liver regeneration
Shikai Hu, Catherine Cao, Minakshi Poddar, Evan Delgado, Sucha Singh, Anya Singh‐Varma, Donna Beer Stolz, Aaron Bell, Satdarshan P. Monga – 20 July 2022
Polycystic ovary syndrome is associated with nonalcoholic steatohepatitis in women of reproductive age
Stephanie S. Maldonado, Joshua Grab, Connie W. Wang, Heather Huddleston, Marcelle Cedars, Monika Sarkar – 20 July 2022 – Polycystic ovary syndrome (PCOS) occurs in approximately 10% of all reproductive‐age women, with over 50% of these patients having imaging‐confirmed nonalcoholic fatty liver disease (NAFLD). Whether PCOS increases the risk for more clinically relevant disease, such as nonalcoholic steatohepatitis (NASH), is unclear. Such findings are relevant to prognosticating risk of progressive liver disease in the growing population of young adults with NAFLD.
Letter to the editor: NAFLD and sarcopenia: Association or causation?
Junwei Zhang, Yiyao Xu, Xin Lu, Haitao Zhao – 20 July 2022
Letter to the editor: Reflection on the no‐association between the presence of fatty liver disease and mortality in the elderly
Cong Ning, Shi‐Tao Jiang, Xin‐Ting Sang – 20 July 2022
Speech patterns and enunciation for encephalopathy determination—A prospective study of hepatic encephalopathy
Andrew M. Moon, Hannah P. Kim, Sarah Cook, Renee T. Blanchard, Katarina L. Haley, Adam Jacks, Jennifer S. Shafer, Michael W. Fried – 20 July 2022 – Hepatic encephalopathy (HE) is a complication of cirrhosis that benefits from early diagnosis and treatment. We aimed to characterize speech patterns of individuals with HE to investigate its potential to diagnose and monitor HE. This was a single‐center prospective cohort study that included participants with cirrhosis with HE (minimal HE [MHE] and overt HE [OHE]), cirrhosis without HE, and participants without liver disease.